Rion Co., Ltd.

TSE:6823 Stock Report

Market Cap: JP¥32.1b

Rion Past Earnings Performance

Past criteria checks 3/6

Rion has been growing earnings at an average annual rate of 8.1%, while the Medical Equipment industry saw earnings growing at 6.2% annually. Revenues have been growing at an average rate of 5.2% per year. Rion's return on equity is 8.6%, and it has net margins of 9.7%.

Key information

8.1%

Earnings growth rate

8.0%

EPS growth rate

Medical Equipment Industry Growth7.8%
Revenue growth rate5.2%
Return on equity8.6%
Net Margin9.7%
Next Earnings Update30 Jan 2025

Recent past performance updates

Recent updates

Here's What To Make Of Rion's (TSE:6823) Decelerating Rates Of Return

Dec 05
Here's What To Make Of Rion's (TSE:6823) Decelerating Rates Of Return

It's Down 33% But Rion Co., Ltd. (TSE:6823) Could Be Riskier Than It Looks

Aug 05
It's Down 33% But Rion Co., Ltd. (TSE:6823) Could Be Riskier Than It Looks

Rion's (TSE:6823) Dividend Will Be ¥28.00

Jul 26
Rion's (TSE:6823) Dividend Will Be ¥28.00

Rion's (TSE:6823) Dividend Will Be ¥28.00

Jul 12
Rion's (TSE:6823) Dividend Will Be ¥28.00

Rion (TSE:6823) Is Increasing Its Dividend To ¥32.00

Mar 04
Rion (TSE:6823) Is Increasing Its Dividend To ¥32.00

Revenue & Expenses Breakdown

How Rion makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TSE:6823 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2426,6652,5918,945889
30 Jun 2426,0682,3698,928889
31 Mar 2425,7262,6528,618889
31 Dec 2325,3992,5118,461887
30 Sep 2325,1712,4528,411887
30 Jun 2324,6982,2958,177887
31 Mar 2323,8681,7997,944887
31 Dec 2223,4891,9827,661926
30 Sep 2223,2181,9917,535926
30 Jun 2222,9492,0527,447926
31 Mar 2222,6352,2297,347926
31 Dec 2121,8501,9937,373764
30 Sep 2121,3531,7587,344764
30 Jun 2121,3381,6977,404764
31 Mar 2120,4661,6367,243764
31 Dec 2020,6981,6447,255902
30 Sep 2020,3041,5017,334902
30 Jun 2020,5741,6327,440902
31 Mar 2021,4651,7797,674902
31 Dec 1921,4351,9607,5161,118
30 Sep 1921,8752,2087,5241,118
30 Jun 1921,5032,0737,5411,118
31 Mar 1921,2892,0027,5721,118
31 Dec 1821,0231,9057,5971,126
30 Sep 1820,7651,9347,4731,126
30 Jun 1820,5491,9567,4031,126
31 Mar 1820,3501,8877,3211,126
31 Dec 1720,0421,9397,2191,099
30 Sep 1719,5811,6787,1671,099
30 Jun 1719,4841,5747,1571,099
31 Mar 1719,1941,4087,2181,099
31 Dec 1619,0031,4046,9081,165
30 Sep 1618,9001,4576,8361,165
30 Jun 1618,7211,4976,6071,165
31 Mar 1618,8591,5946,4791,165
31 Dec 1519,1141,4576,7291,060
30 Sep 1518,9721,4216,7061,060
30 Jun 1518,9781,4806,7081,060
31 Mar 1518,7581,4276,6211,060
31 Dec 1418,7731,4966,5521,067
30 Sep 1418,6621,3926,5391,067
30 Jun 1418,4941,2586,5571,067
31 Mar 1418,5101,3166,5001,067
31 Dec 1317,8741,1966,527913

Quality Earnings: 6823 has high quality earnings.

Growing Profit Margin: 6823's current net profit margins (9.7%) are lower than last year (9.7%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 6823's earnings have grown by 8.1% per year over the past 5 years.

Accelerating Growth: 6823's earnings growth over the past year (5.7%) is below its 5-year average (8.1% per year).

Earnings vs Industry: 6823 earnings growth over the past year (5.7%) exceeded the Medical Equipment industry 5.6%.

Return on Equity

High ROE: 6823's Return on Equity (8.6%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 10:49
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Rion Co., Ltd. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jiro KojimaDaiwa Securities Co. Ltd.
Masatoshi NagataIchiyoshi Research Institute Inc.
Hidekazu MiyaharaMarusan Securities Co. Ltd.